ToxSci Advance Access published online on October 13, 2007
Toxicological Sciences, doi:10.1093/toxsci/kfm260
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press 2007.
Comparison of Kidney Injury Molecule-1 and Other Nephrotoxicity Biomarkers in Urine and Kidney Following Acute Exposure to Gentamicin, Mercury, and Chromium
* Center for Devices and Radiological Health
Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993
Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115
Corresponding author: Peter L Goering, PhD, Center for Devices and Radiological Health, Food and Drug Administration, White Oak Life Sciences Lab, WO64 – 4064, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993-0002, Email: peter.goering{at}fda.hhs.gov, Tel: 301-796-0253, FAX: 301-796-9826
Received August 28, 2007; revision received October 3, 2007; accepted October 5, 2007
 |
Abstract |
|---|
Sensitive biomarkers are needed to detect kidney injury at the earliest stages. The objective of this study was to determine whether the appearance of kidney injury molecule-1 (Kim-1) protein ectodomain in urine and kidney injury molecule-1/hepatitis A viral cellular receptor-1 (Kim-1/Havcr1) gene expression in kidney tissue may be more predictive of renal injury after exposure to nephrotoxicants when compared to traditionally used biomarkers. Male Sprague-Dawley rats were injected with a range of doses of gentamicin, mercury (HgCl2) or chromium (K2Cr2O7). The results showed that increases in urinary Kim-1 and kidney Kim-1/Havcr1 gene expression paralleled the degree of severity of renal histopathology, and were detected at lower doses of nephrotoxicants when compared to BUN, serum creatinine, and urinary N-acetyl-ß-glucosamidase (NAG). In a time course study, urinary Kim-1 was elevated within 24 hr after exposure to gentamicin (100 mg/kg), Hg (0.25 mg /kg) or Cr (5 mg/kg) and remained elevated through 72 hr. NAG responses were nephrotoxicant-dependent with elevations occurring early (gentamicin), late (Cr), or no change (Hg). At 72 hr after treatment with any of the three nephrotoxicants, there was increased Kim-1 immunoreactivity and necrosis involving approximately 50% of the proximal tubules; however, only urinary Kim-1 was significantly increased while BUN, serum creatinine and NAG were not different from controls. In rats treated with the hepatotoxicant galactosamine (1.1 mg/kg), serum ALT was increased, but no increase in urinary Kim-1 was observed. Urinary Kim-1 and kidney Kim-1/Havcr1 expression appear to be sensitive and tissue-specific biomarkers that will improve detection of early acute kidney injury following exposure to nephrotoxic chemicals and drugs.
Key Words: acute kidney injury; nephrotoxicity biomarkers; kidney injury molecule-1; mercury; chromium; gentamicin.
yuzhao.zhou{at}fda.hhs.gov, vvaidya{at}partners.org, ronald.brown{at}fda.hhs.gov, rosenzweigb{at}fda.hhsl.gov, thompsonk{at}fda.hhs.gov, zhangj{at}fda.hhs.gov, millerte{at}fda.hhs.gov, joseph_bonventre{at}hms.harvard.edu , peter.goering{at}fda.hhs.gov
Supported in part by an appointment to the Research Fellowship Program administered by the Oak Ridge Associated Universities through a contract with the U.S. Food and Drug Administration.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. V. Bonventre Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3265 - 3268. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, P. L. Goering, P. Espandiari, M. Shaw, J. V. Bonventre, V. S. Vaidya, R. P. Brown, J. Keenan, C. G. Kilty, N. Sadrieh, et al. Differences in Immunolocalization of Kim-1, RPA-1, and RPA-2 in Kidneys of Gentamicin-, Cisplatin-, and Valproic Acid-Treated Rats: Potential Role of iNOS and Nitrotyrosine Toxicol Pathol, August 1, 2009; 37(5): 629 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sieber, D. Hoffmann, M. Adler, V. S. Vaidya, M. Clement, J. V. Bonventre, N. Zidek, E. Rached, A. Amberg, J. J. Callanan, et al. Comparative Analysis of Novel Noninvasive Renal Biomarkers and Metabonomic Changes in a Rat Model of Gentamicin Nephrotoxicity Toxicol. Sci., June 1, 2009; 109(2): 336 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Rees and R. Kain Kim-1/Tim-1: from biomarker to therapeutic target? Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3394 - 3396. [Full Text] [PDF]
|
|
|
|
|
|
E. Rached, D. Hoffmann, K. Blumbach, K. Weber, W. Dekant, and A. Mally Evaluation of Putative Biomarkers of Nephrotoxicity after Exposure to Ochratoxin A In Vivo and In Vitro Toxicol. Sci., June 1, 2008; 103(2): 371 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, R. P. Brown, M. Shaw, V. S. Vaidya, Y. Zhou, P. Espandiari, N. Sadrieh, M. Stratmeyer, J. Keenan, C. G. Kilty, et al. Immunolocalization of Kim-1, RPA-1, and RPA-2 in Kidney of Gentamicin-, Mercury-, or Chromium-Treated Rats: Relationship to Renal Distributions of iNOS and Nitrotyrosine Toxicol Pathol, April 1, 2008; 36(3): 397 - 409. [Abstract] [Full Text] [PDF]
|
|